血液チューブセット市場：タイプ、用途、エンドユーザー別-2025-2030年の世界予測

血液チューブセット市場は、2023年に9億2,134万米ドルと評価され、2024年には9億7,324万米ドルに達すると予測され、CAGR 6.92%で成長し、2030年には14億7,234万米ドルに達すると予測されています。

血液チューブセット市場は医療分野で極めて重要であり、主に透析や輸血中の血液製剤の安全かつ効率的な移送を促進します。これらのセットは、患者と透析装置や血液保存装置をつなぐ重要な部品であり、血液の純度を維持し、汚染を防ぐために必要であることを強調しています。主に病院、クリニック、透析センターなどのヘルスケア施設で使用されています。同市場の最終用途には、主に病院やクリニックが含まれ、在宅ケア・ソリューションを選択する患者が増加していることから、在宅ヘルスケア・サービスも含まれます。市場に影響を与える主な成長要因としては、慢性腎臓病の有病率の増加、高齢化人口の増加、世界の透析患者数の増加などが挙げられます。さらに、血液チューブセットの有効性と安全性の向上を目指した技術の進歩は、市場プレーヤーに大きなビジネスチャンスをもたらしています。しかし、厳しい規制基準や高度な血液チューブセットに関連する高コストが課題となっています。腎移植のような代替治療との競合も市場成長に影響を与えます。こうした課題にもかかわらず、血流をより正確に監視・制御できるスマート技術を組み込んだ、環境にやさしく費用対効果の高いチューブセットの開発には、革新的な機会が存在します。研究は、生体適合性の向上と感染リスクの低減に重点を置くことも可能であり、競争市場において独自の販売提案となるであろう。世界市場はダイナミックであり、医療インフラの整備状況や患者の人口動態に左右される需要の地域差が特徴です。潜在的なビジネスチャンスを生かすために、企業はアンメットニーズを満たすための研究開発に投資し、市場での存在感を高めるために戦略的提携や買収を検討すべきです。このようなアプローチは、血液チューブセット市場の持続可能な成長を促進しながら課題を克服するのに役立つと思われます。

市場力学：急速に進化する血液チューブセット市場の主要市場インサイトを公開

血液チューブセット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性腎臓病の罹患率の増加
  • ヘルスケア施設の拡大・整備の進展
  • 腎臓の健康に対する意識の高まりと早期診断のためのスクリーニングプログラム
• 市場抑制要因
  • 血液透析に伴う高コスト
• 市場機会
  • ヘルスケアへのアクセス改善と慢性疾患の管理を目的とした政府のイニシアティブの高まり
  • ヘルスケア・インフラへの政府および民間企業の投資の増加
• 市場の課題
  • 厳しい規制要件と物流の課題

ポーターの5つの力：血液チューブセット市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液チューブセット市場における外部からの影響の把握

外部マクロ環境要因は、血液チューブセット市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血液チューブセット市場における競合情勢の把握

血液チューブセット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血液チューブセット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液チューブセット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血液チューブセット市場における成功への道筋を描く

血液チューブセット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性腎臓病の発症率は世界的に増加している
    • ヘルスケア施設の拡大と改善
    • 腎臓の健康と早期診断のためのスクリーニングプログラムに関する意識の向上
  • 抑制要因
    • 血液透析に伴う高額な費用
  • 機会
    • ヘルスケアへのアクセス改善と慢性疾患の管理を目的とした政府の取り組みが増加
    • ヘルスケアインフラへの政府および民間セクターの投資の増加
  • 課題
    • 厳しい規制要件と物流上の課題
• 市場セグメンテーション分析
  • タイプ：血液透析および医療用途における静脈血チューブセットの需要増加
  • エンドユーザー：ヘルスケア現場における血液チューブセットの利用拡大
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血液チューブセット市場：タイプ別

• 動脈血チューブセット
• 静脈血チューブセット

第7章 血液チューブセット市場：用途別

• アフェレーシス
• 血液透析
• 腹膜透析
• 血漿交換

第8章 血液チューブセット市場：エンドユーザー別

• 外来手術センター
• 血液銀行
• 透析センター
• 在宅ヘルスケア
• 病院

第9章 南北アメリカの血液チューブセット市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血液チューブセット市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血液チューブセット市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 日本の医療企業ニプロ、グリーンビルに米国初の製造工場を計画
  • ヘモネティクス・コーポレーション、アチューン・メディカルの買収を完了
  • CMLバイオテックが世界初の統合型採血管製造機を導入
• 戦略分析と提言

企業一覧

• 1. Asahi Kasei Medical Co., Ltd.
• 2. B. Braun SE
• 3. Baxter International, Inc.
• 4. Farmasol srl.
• 5. Fresenius Kabi AG
• 6. Guangdong Biolight Meditech Co., Ltd.
• 7. Haemonetics Corporation
• 8. Hindustan Syringes & Medical Devices Ltd
• 9. JMS Co., Ltd.
• 10. Medical Components, Inc.
• 11. Nikkiso Co.,
• 12. NIPRO CORPORATION
• 13. Perfect Medical Ind. Co., Ltd.
• 14. Poly Medicure Limited
• 15. SB-Kawasumi Laboratories, Inc.
• 16. Shandong Weigao Group Medical Polymer Co.,Ltd.
• 17. Terumo Medical Corporation
• 18. Toray Medical Co., Ltd.
• 19. Vogt Medical Vertrieb GmbH.
• 20. Weigao group

LIST OF FIGURES

• FIGURE 1. BLOOD TUBING SET MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD TUBING SET MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD TUBING SET MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD TUBING SET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD TUBING SET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD TUBING SET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD TUBING SET MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD TUBING SET MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BLOOD TUBING SET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BLOOD TUBING SET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BLOOD TUBING SET MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BLOOD TUBING SET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD TUBING SET MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD TUBING SET MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD TUBING SET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD TUBING SET MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD TUBING SET MARKET SIZE, BY ARTERIAL BLOOD TUBING SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD TUBING SET MARKET SIZE, BY VENOUS BLOOD TUBING SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD TUBING SET MARKET SIZE, BY APHERESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD TUBING SET MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD TUBING SET MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD TUBING SET MARKET SIZE, BY PLASMAPHERESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD TUBING SET MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD TUBING SET MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD TUBING SET MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD TUBING SET MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD TUBING SET MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BLOOD TUBING SET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BLOOD TUBING SET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BLOOD TUBING SET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BLOOD TUBING SET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BLOOD TUBING SET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. BLOOD TUBING SET MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. BLOOD TUBING SET MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Tubing Set Market was valued at USD 921.34 million in 2023, expected to reach USD 973.24 million in 2024, and is projected to grow at a CAGR of 6.92%, to USD 1,472.34 million by 2030.

The blood tubing set market is pivotal in the medical sector, primarily facilitating the safe and efficient transfer of blood products during dialysis or blood transfusion. These sets are essential components connecting the patient to the dialysis machine or blood storage units, highlighting their necessity in maintaining blood purity and preventing contamination. They find application mainly in healthcare facilities such as hospitals, clinics, and specialized dialysis centers. The market's end-use scope involves primarily hospitals and clinics, along with home healthcare services, as more patients opt for at-home care solutions. Key growth factors impacting the market include the increasing prevalence of chronic kidney diseases, a growing aging population, and a rise in the number of dialysis patients globally. Additionally, technological advancements aiming at improving the efficacy and safety of blood tubing sets create significant opportunities for market players. However, stringent regulatory standards and the high cost associated with advanced tubing sets present challenges. The competition from alternative treatments, such as kidney transplants, also affects market growth. Despite these challenges, innovative opportunities exist in the development of eco-friendly and cost-effective tubing sets, incorporating smart technology that can monitor and control blood flow more accurately. Research could focus on enhancing biocompatibility and reducing the risk of infection, which would serve as a unique selling proposition in a competitive market. The global market is dynamic, characterized by regional variances in demand, driven by the availability of healthcare infrastructure and patient population demographics. To capitalize on potential opportunities, companies should invest in R&D aimed at fulfilling unmet needs and look towards strategic collaborations or acquisitions to enhance their market presence. This approach will help in navigating the challenges while driving sustainable growth in the blood tubing set market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Tubing Set Market

The Blood Tubing Set Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of chronic kidney diseases globally
  • Growing expansion and improvement of healthcare facilities
  • Increased awareness about kidney health and screening programs for early diagnosis
• Market Restraints
  • High costs associated with hemodialysis
• Market Opportunities
  • Rising government initiatives aimed at improving access to healthcare and managing chronic diseases
  • Increased government and private sector investments in healthcare infrastructure
• Market Challenges
  • Stringent regulatory requirements and logistical challenges

Porter's Five Forces: A Strategic Tool for Navigating the Blood Tubing Set Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Tubing Set Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Tubing Set Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Tubing Set Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Tubing Set Market

A detailed market share analysis in the Blood Tubing Set Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Tubing Set Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Tubing Set Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Tubing Set Market

A strategic analysis of the Blood Tubing Set Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Tubing Set Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International, Inc., Farmasol srl., Fresenius Kabi AG, Guangdong Biolight Meditech Co., Ltd., Haemonetics Corporation, Hindustan Syringes & Medical Devices Ltd, JMS Co., Ltd., Medical Components, Inc., Nikkiso Co.,, NIPRO CORPORATION, Perfect Medical Ind. Co., Ltd., Poly Medicure Limited, SB-Kawasumi Laboratories, Inc., Shandong Weigao Group Medical Polymer Co.,Ltd., Terumo Medical Corporation, Toray Medical Co., Ltd., Vogt Medical Vertrieb GmbH., and Weigao group.

Market Segmentation & Coverage

This research report categorizes the Blood Tubing Set Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Arterial Blood Tubing Sets and Venous Blood Tubing Sets.
• Based on Application, market is studied across Apheresis, Hemodialysis, Peritoneal Dialysis, and Plasmapheresis.
• Based on End User, market is studied across Ambulatory Surgical Centers, Blood Banks, Dialysis Centers, Home Healthcare, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of chronic kidney diseases globally
    • 5.1.1.2. Growing expansion and improvement of healthcare facilities
    • 5.1.1.3. Increased awareness about kidney health and screening programs for early diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with hemodialysis
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising government initiatives aimed at improving access to healthcare and managing chronic diseases
    • 5.1.3.2. Increased government and private sector investments in healthcare infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements and logistical challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing demand for venous blood tubing sets in hemodialysis and medical applications
  • 5.2.2. End-User: Expanding utilization of blood tubing sets across healthcare Settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Tubing Set Market, by Type

• 6.1. Introduction
• 6.2. Arterial Blood Tubing Sets
• 6.3. Venous Blood Tubing Sets

7. Blood Tubing Set Market, by Application

• 7.1. Introduction
• 7.2. Apheresis
• 7.3. Hemodialysis
• 7.4. Peritoneal Dialysis
• 7.5. Plasmapheresis

8. Blood Tubing Set Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Blood Banks
• 8.4. Dialysis Centers
• 8.5. Home Healthcare
• 8.6. Hospitals

9. Americas Blood Tubing Set Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood Tubing Set Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood Tubing Set Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Japanese medical firm Nipro plans first U.S. manufacturing plant in Greenville
  • 12.3.2. Haemonetics Corporation completes acquisition of Attune Medical
  • 12.3.3. CML Biotech installs world's first integrated blood collection tube manufacturing machine
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Asahi Kasei Medical Co., Ltd.
• 2. B. Braun SE
• 3. Baxter International, Inc.
• 4. Farmasol srl.
• 5. Fresenius Kabi AG
• 6. Guangdong Biolight Meditech Co., Ltd.
• 7. Haemonetics Corporation
• 8. Hindustan Syringes & Medical Devices Ltd
• 9. JMS Co., Ltd.
• 10. Medical Components, Inc.
• 11. Nikkiso Co.,
• 12. NIPRO CORPORATION
• 13. Perfect Medical Ind. Co., Ltd.
• 14. Poly Medicure Limited
• 15. SB-Kawasumi Laboratories, Inc.
• 16. Shandong Weigao Group Medical Polymer Co.,Ltd.
• 17. Terumo Medical Corporation
• 18. Toray Medical Co., Ltd.
• 19. Vogt Medical Vertrieb GmbH.
• 20. Weigao group